Kremer M, Cabras A D, Fend F, Schulz S, Schwarz K, Hoefler H, Werner M
Institut fuer Allgemeine Pathologie und Pathologische Anatomie der Technischen Universitaet Muenchen, Germany.
Hum Pathol. 2000 Jul;31(7):847-53. doi: 10.1053/hupa.2000.8445.
The differentiation of benign lymphoid infiltrates from nodular infiltrates of B-cell lymphoma is difficult in bone marrow (BM) biopsy specimens taken from patients with non-Hodgkin's lymphoma (NHL). We investigated whether the determination of clonality by polymerase chain reaction (PCR) analysis of the immunoglobulin heavy chain (IgH) genes could be of help for the distinction of benign and malignant lymphoid infiltrates. BM biopsy specimens of 28 patients were studied, comparing PCR of entire bone marrow sections with microdissected nodular lymphoid infiltrates. Patients were divided into 4 groups according to morphologic criteria: group 1 (n = 12), positive for B-NHL infiltration; group 2 (n = 5), suspicious for infiltration by known B-NHL; group 3 (n = 5), morphologically benign infiltrates in patients with B-NHL; group 4 (n = 6), benign lymphoid infiltrates in patients without history of B-NHL. PCR products were analyzed using polyacrylamide gels and a fragment length analysis system (Genescan). PCR of whole sections showed clonal amplification products in all cases of group 1 and 1 case of group 2. PCR analysis from microdissected nodular infiltrates showed the presence of a clonal B-cell population in 5 additional cases of groups 2 and 4. In 3 of these cases, clonal rearrangements of corresponding size were obtained from the primary lymphoma biopsy specimens. None of the cases of group 3 showed evidence of a clonal population with either technique. The results indicate that microdissection of small nodular lymphoid infiltrates from paraffin-BM sections increases the sensitivity of IgH gene rearrangement analysis. To avoid detection of biologically irrelevant clonal populations, comparison of PCR products obtained from the BM and the primary lymphoma biopsy is advisable.
在取自非霍奇金淋巴瘤(NHL)患者的骨髓(BM)活检标本中,区分良性淋巴样浸润与B细胞淋巴瘤的结节性浸润很困难。我们研究了通过免疫球蛋白重链(IgH)基因的聚合酶链反应(PCR)分析来确定克隆性是否有助于区分良性和恶性淋巴样浸润。对28例患者的BM活检标本进行了研究,将整个骨髓切片的PCR结果与显微切割的结节性淋巴样浸润结果进行比较。根据形态学标准将患者分为4组:第1组(n = 12),B-NHL浸润阳性;第2组(n = 5),怀疑有已知B-NHL浸润;第3组(n = 5),B-NHL患者中的形态学良性浸润;第4组(n = 6),无B-NHL病史患者的良性淋巴样浸润。使用聚丙烯酰胺凝胶和片段长度分析系统(Genescan)分析PCR产物。整个切片的PCR在第1组的所有病例和第2组的1例中显示出克隆扩增产物。显微切割的结节性浸润的PCR分析显示,第2组和第4组另外5例中存在克隆性B细胞群体。在其中3例中,从原发性淋巴瘤活检标本中获得了相应大小的克隆重排。第3组的所有病例用两种技术均未显示克隆群体的证据。结果表明,从石蜡包埋的BM切片中显微切割小的结节性淋巴样浸润可提高IgH基因重排分析的敏感性。为避免检测到生物学上无关的克隆群体,建议比较从BM和原发性淋巴瘤活检获得的PCR产物。